CONCLUSIONS: Critical gaps persist-ancestry bias, lack of unified quantitative risk models, and limited therapy translation. Future priorities include diversifying genomic cohorts, establishing multi-omic birth cohorts, developing early-detection biomarkers for the perinatal window, and evaluating targeted interventions in genetically defined subgroups. This integrative framework aims to guide developmentally sensitive, precision-oriented approaches to NDD research and clinical care.
